| 000 | 01686 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516081303.0 | ||
| 264 | 0 | _c20140415 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1520-5762 | ||
| 024 | 7 |
_a10.3109/03639045.2012.662507 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSigfridsson, Kalle | |
| 245 | 0 | 0 |
_aEarly pharmaceutical evaluation of a crystalline and hygroscopic GABAB receptor agonist. _h[electronic resource] |
| 260 |
_bDrug development and industrial pharmacy _cOct 2013 |
||
| 300 |
_a1573-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDrug Contamination |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aDrug Storage |
| 650 | 0 | 4 | _aElectrophoresis, Capillary |
| 650 | 0 | 4 |
_aGABA-A Receptor Agonists _xanalysis |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xanalysis |
| 650 | 0 | 4 |
_aHot Temperature _xadverse effects |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aHydrophobic and Hydrophilic Interactions |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMicroscopy, Electron, Scanning |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aPhosphinic Acids _xanalysis |
| 650 | 0 | 4 | _aPowder Diffraction |
| 650 | 0 | 4 |
_aPropylamines _xanalysis |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 650 | 0 | 4 | _aStereoisomerism |
| 700 | 1 | _aAndersson, Thomas | |
| 700 | 1 | _aBerntsson, Veronica | |
| 700 | 1 | _aWang, Yudong | |
| 773 | 0 |
_tDrug development and industrial pharmacy _gvol. 39 _gno. 10 _gp. 1573-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/03639045.2012.662507 _zAvailable from publisher's website |
| 999 |
_c21578011 _d21578011 |
||